WONDFO BIOTECH(SZ:300482)2022-12-07 08:41Group 1: Market Overview - The company has a high proportion of overseas market presence, with a focus on expanding quantitative products domestically [2] - New product registration in foreign markets takes longer, but sales increase significantly post-registration [2] - The largest market for similar products abroad is Europe, with a focus on OEM brands in large chain supermarkets [3] Group 2: Product and Sales Channels - The pregnancy testing market is primarily through supermarkets, with a growing emphasis on e-commerce platforms [3] - The company has a stable distribution network with no significant additional costs, mainly focusing on e-commerce expenses [3] - Infectious disease products are primarily self-branded, with some OEM for drugs and pregnancy tests [4] Group 3: Future Growth and Development - The company anticipates growth in drug testing markets outside of China and the U.S., with new testing varieties expected [4] - The market for chronic disease products is primarily quantitative, with significant sales potential in community healthcare settings [4] - The sales team has increased by approximately 10-20% domestically, with a larger demand in Europe and the U.S. [4] Group 4: New Product Development - The company plans to launch new platforms, including dry chemistry and microfluidics, in addition to existing qualitative and quantitative platforms [5] - Investments have been made in portable ECG devices as part of health management preparations [5]